C030048B08Rik Inhibitors
Chemical inhibitors of C030048B08Rik can modulate the activity of this protein by targeting various signaling pathways and enzymatic activities that are crucial for its function. Staurosporine, a broad-spectrum protein kinase inhibitor, can inhibit C030048B08Rik by preventing essential phosphorylation events, assuming that C030048B08Rik's activity is contingent upon such modifications. Similarly, rapamycin's action on mTOR, a regulatory kinase, can lead to decreased activity of C030048B08Rik if this protein operates downstream of or is regulated by the mTOR pathway. Compounds like wortmannin and LY294002, both of which are specific phosphoinositide 3-kinase (PI3K) inhibitors, can impede signaling pathways reliant on PI3K activity. If C030048B08Rik is involved in such pathways, the inhibition of PI3K can diminish the protein's function.
Furthermore, the MEK inhibitors PD98059 and U0126 can prevent the activation of the MAPK/ERK pathway, potentially reducing C030048B08Rik activity if it is regulated by this pathway. SB203580's specificity for p38 MAP kinase and SP600125's inhibition of c-Jun N-terminal kinase (JNK) can also decrease C030048B08Rik activity if its function is dependent on these kinases. PP2, which selectively targets Src family tyrosine kinases, can suppress C030048B08Rik activity by inhibiting signaling pathways regulated by these kinases. Y-27632, a selective inhibitor of Rho-associated protein kinase (ROCK), can reduce the activity of C030048B08Rik if it is involved in ROCK-regulated pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, and if C030048B08Rik is a kinase or interacts with kinase-dependent signaling pathways, staurosporine could inhibit its function by preventing phosphorylation events necessary for its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulatory kinase. If C030048B08Rik functions downstream of or is regulated by the mTOR pathway, rapamycin's inhibition of mTOR could lead to a decrease in C030048B08Rik activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a specific inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K by wortmannin would impede signaling pathways that rely on PI3K activity, which could include pathways that C030048B08Rik is involved in, leading to decreased function of C030048B08Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor, and it functions similarly to wortmannin. By inhibiting PI3K, LY294002 could disrupt signaling pathways important for C030048B08Rik's functional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK1, which is upstream of ERK in the MAPK pathway. Inhibition of MEK1 by PD98059 would prevent the activation of ERK and subsequent phosphorylation events, potentially inhibiting C030048B08Rik if it is regulated by the MAPK pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that prevents the activation of MAPK/ERK. If C030048B08Rik is part of the MAPK/ERK pathway or is regulated by it, inhibition by U0126 would lead to decreased activity of C030048B08Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38 MAP kinase activity, SB203580 could functionally inhibit C030048B08Rik if it operates within the p38 MAPK pathway or is regulated by it. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If C030048B08Rik's activity is JNK-dependent, inhibition of JNK by SP600125 would result in decreased activity of C030048B08Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. If C030048B08Rik is a non-receptor tyrosine kinase or is associated with signaling pathways regulated by Src kinases, PP2 could inhibit these pathways, leading to a decrease in C030048B08Rik activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 selectively inhibits Rho-associated protein kinase (ROCK). If C030048B08Rik is involved in pathways regulated by ROCK, inhibition of ROCK by Y-27632 could result in decreased functional activity of C030048B08Rik. | ||||||